We are live on
!
Find out more
NCM
Narwhal Capital Management Portfolio holdings
AUM
$1.45B
1-Year Est. Return
28.39%
This Fund
S&P 500
This Quarter
Est. Return
+5.25%
1 Year Est. Return
+28.39%
3 Year Est. Return
+93.85%
5 Year Est. Return
+119.75%
10 Year Est. Return
+391.36%
AUM
$435M
AUM Growth
+$31.6M
(+7.8%)
Cap. Flow
+$12.6M
Cap. Flow
% of AUM
2.89%
Top 10 Holdings %
Top 10 Hldgs %
28.37%
Holding
157
New
10
Increased
69
Reduced
42
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.63M |
| 2 |
Abbott
ABT
|
+$2.55M |
| 3 |
Johnson Controls International
JCI
|
+$1.93M |
| 4 |
Apple
AAPL
|
+$1.7M |
| 5 |
Procter & Gamble
PG
|
+$1.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vulcan Materials
VMC
|
+$9.94M |
| 2 |
CVS Health
CVS
|
+$1.86M |
| 3 |
HCA Healthcare
HCA
|
+$1.76M |
| 4 |
Walt Disney
DIS
|
+$1.69M |
| 5 |
CELG
Celgene Corp
CELG
|
+$1.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.1% |
| 2 | Financials | 12.7% |
| 3 | Healthcare | 10.25% |
| 4 | Industrials | 9.4% |
| 5 | Communication Services | 8.84% |
Similar funds
SIA
VIP
SIM
CHAM
HTI
SWP
L7C
WBC
Narwhal Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, Narwhal Capital Management held 157 positions worth $435M, up 7.8% from $403M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Narwhal Capital Management's Q4 2017 filing shows 10 new, 69 increased, 42 reduced and 10 closed positions. Its largest new stake was Abbott: 45,967 shares worth $2.62M. The largest sale was Vulcan Materials, an estimated $9.94M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- Narwhal Capital Management's largest Q4 2017 buy was Abbott: 45,967 shares worth $2.62M.
- Narwhal Capital Management added most to UnitedHealth in Q4 2017, an estimated $2.63M increase.
- Narwhal Capital Management's biggest Q4 2017 reduction was Vulcan Materials, cutting an estimated $9.94M.
- Narwhal Capital Management fully exited Celgene Corp in Q4 2017, selling an estimated $1.29M.
- Narwhal Capital Management's ten largest holdings make up 28% of its $435M portfolio in Q4 2017.
- Narwhal Capital Management opened 10 new positions and closed 10 in Q4 2017.
- Narwhal Capital Management's portfolio value rose 7.8% quarter-over-quarter to $435M.
Based on Narwhal Capital Management's 13F filing for Q4 2017, filed 23 Jan 2018.